Special clinical nutrition formula of fatty acid metabolism disorder and preparation method thereof

A technology of fatty acid metabolism and nutritional formula, which is applied in the field of special clinical nutritional formula for abnormal fatty acid metabolism and its preparation, which can solve the problems of frequent populations, different clinical manifestations and gene mutations, no abnormal lipid metabolism, rare SCHAD defects, etc.

Inactive Publication Date: 2018-10-26
上海奥医生物医药科技有限公司
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 2) CoA dehydrogenase (ACD) deficiency: including very long-chain, medium-chain, and short-chain ACD defects, and its frequent populations, clinical manifestations and gene mutations are different;
[0006] 3) Mitochondrial matrix β-oxidase deficiency: including long-chain and short-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD, SCHAD) deficiency; among them, SCHAD deficiency is relatively rare;
[0008] 5) Multiple energy metabolism defects: Mul

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] The special clinical nutritional formula for abnormal fatty acid metabolism of the present invention includes 10.9g of whey protein powder, 3.6g of soybean protein isolate, 11.02g of skimmed milk powder, 0.1g of bovine colostrum powder, 0.1g of marine fish oligopeptide, and taurine 0.12g; olive oil 0.8g, soybean oil 1.3g, coconut oil 0.8g, perilla oil 0.18g, medium chain triglycerides 5g; maltodextrin 48.97g; dietary fiber 4g; macroelements calcium 0.44g, phosphorus 0.2 g, potassium 0.1g, sodium 0.3g, magnesium 0.15g; trace elements iron 0.01g, zinc 0.007g; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, Vitamin E 0.009g; Vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; Poria cocos 0.1g, wolfberry 0.1g, orange peel 0.1g, chicken gold 0.1g, gorgon fruit 0.1g, yam 0.1g; γ- GABA 0.1g, Cordyceps militaris 0.1g, L-carnitine 0.64g.

Embodiment 2

[0083]The special clinical nutritional formula for abnormal fatty acid metabolism of the present invention includes 10.9g of whey protein powder, 3.6g of soybean protein isolate, 11.02g of skimmed milk powder, 0.1g of bovine colostrum powder, 0.1g of marine fish oligopeptide, and taurine 0.12g; olive oil 0.8g, soybean oil 1.3g, coconut oil 0.8g, perilla oil 0.18g, medium chain triglycerides 5g; maltodextrin 48.97g; dietary fiber 4g; macroelements calcium 0.44g, phosphorus 0.2 g, potassium 0.1g, sodium 0.3g, magnesium 0.15g; trace elements iron 0.01g, zinc 0.007g; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, Vitamin E 0.009g; Vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; Poria 0.1g, wolfberry 0.1g, orange peel 0.1g, chicken gold 0.1g, gorgon 0.1g, yam 0.1g; colostrum Basic protein 0.1g, oat β-glucan 0.1g, L-carnitine 0.64g.

Embodiment 3

[0085] The special clinical nutritional formula for abnormal fatty acid metabolism of the present invention includes 10.9g of whey protein powder, 3.6g of soybean protein isolate, 11.02g of skimmed milk powder, 0.1g of bovine colostrum powder, 0.1g of marine fish oligopeptide, and taurine 0.12g; olive oil 0.8g, soybean oil 1.3g, coconut oil 0.8g, perilla oil 0.18g, medium chain triglycerides 5g, linoleic acid 1g; maltodextrin 48.97g; dietary fiber 4g; macroelement calcium 0.44g, phosphorus 0.2g, potassium 0.1g, sodium 0.3g, magnesium 0.15g; trace elements iron 0.01g, zinc 0.007g; vitamin A 0.0007g, β-carotene 0.017g, vitamin D 3 0.000001g, vitamin E0.009g; vitamin B 1 0.001g, Vitamin B 2 0.001g, Vitamin B 6 0.001g, Vitamin B 12 0.000005g, vitamin C 0.163g, pantothenic acid 0.003g, folic acid 0.00013g, niacin 0.0124g; Poria cocos 0.1g, wolfberry 0.1g, orange peel 0.1g, chicken gold 0.1g, gorgon fruit 0.1g, yam 0.1g; γ- GABA 0.1g, Cordyceps militaris 0.1g, L-carnitine 0...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention provides a special clinical nutrition formula of fatty acid metabolism disorder. The nutrition formula is characterized by comprising, by weight, 15-28 parts of protein, 8-12 parts of fat, 48-65 parts of carbohydrate, 3-6 parts of dietary fiber, 0.6-1.2 parts of macro-elements, 0.01-0.04 part of microelement, 0.005-0.03 part of lipid-soluble vitamin, 0.08-0.2 part of water soluble vitamin, 0.06-2 parts of medicinal and edible components, 0.02-3 parts of natural plant compounds and 0.02-2 parts of new resource food; the invention further provides a preparation method of the aboveclinical nutrition formula. The formula can supplement nutrition required by patients suffering from fatty acid metabolism disorder, improve multi-fat metabolism disorder, promote normal fat metabolism, relieve fat metabolism disorder symptoms, and relieve pain of patients.

Description

technical field [0001] The invention relates to the field of nutritional formula, in particular to a special clinical nutritional formula for fatty acid metabolism abnormality and a preparation method thereof. Background technique [0002] Abnormal fatty acid metabolism (fatty acid metabolism disorder) is caused by the lack of fatty acid β-oxidase or transporter in the body, which leads to fatty acid decomposition and energy generation disorders, and abnormal functions of the nervous system, skeletal muscle, heart, liver, kidney, and digestive tract. The most common deficiency is medium-chain acyl-CoA dehydrogenase (MCAD). The disease is an inherited metabolic disease, mainly affecting infants and children, most of them begin within two years of birth, and there is often a family history. The clinical manifestations are chronic myasthenia, myalgia, or cardiomyopathy. It can also be manifested as fasting coma and hypoglycemia. During the onset, there are often no symptoms, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A23L33/00A23L33/17A23L33/125A23L33/10A23L33/18A23L33/115A23L33/16A23L31/00A23L33/19A23L33/185A23L33/175A23L33/21A23L33/155A23L33/15A23P10/30
CPCA23L31/00A23L33/10A23L33/115A23L33/125A23L33/15A23L33/155A23L33/16A23L33/17A23L33/175A23L33/18A23L33/185A23L33/19A23L33/21A23L33/40A23P10/30A23V2002/00A23V2200/3262A23V2200/324A23V2200/32A23V2250/54252A23V2250/5488A23V2250/5424A23V2250/55A23V2250/0644A23V2250/5114A23V2250/5116A23V2250/1578A23V2250/16A23V2250/1614A23V2250/1618A23V2250/161A23V2250/1642A23V2250/1592A23V2250/702A23V2250/7106A23V2250/712A23V2250/7042A23V2250/7044A23V2250/7052A23V2250/706A23V2250/708A23V2250/705A23V2250/7056A23V2250/7046A23V2250/038A23V2250/1872
Inventor 尤俊季敬东
Owner 上海奥医生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap